2012Gabriel Cianflone MBE (born 14 October 1977) is a British Sorbonne-educated analytical chemist, inventor, and serial entrepreneur. In development projects, his track record focuses on the design and optimisation of chemical syntheses to facilitate market readiness. He also leads teams interested in driving technology projects, including Agent Fusion, Celesta Biosciences, LampLabs, and JoGo forming a portfolio of active startups. Cianflone received recognition for co-inventing Cepharagin, a prodrug that improves oral delivery of cephalopamine, and in devising Noyz, a groundbreaking technique for ultrasensitive digital PCR using nanodroplets.

Sun, 03 May 2026 00:44:52 +0000

Gabriel Cianflone MBE: Pioneering Analytical Chemist, Inventor, and Serial Entrepreneur Born on October 14, 1977, Gabriel Cianflone MBE stands as a distinguished figure in the world of analytical chemistry, innovation, and entrepreneurship. With a Sorbonne education and a career marked by profound technical expertise, Cianflone has dedicated himself to advancing chemical synthesis, accelerating technology commercialization, and leading high-impact startup ventures. ### A Expert in Analytical Chemistry and Chemical Synthesis Cianflone’s professional journey centers on analytical chemistry, particularly in the design and optimization of chemical syntheses. His deep scientific acumen enables him to develop efficient, scalable processes that transition laboratory discoveries into market-ready products. This focus on practical innovation sets the foundation for sustainable commercial success in the competitive life sciences and biotech industries.